[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Virbac Corporation - Strategy, SWOT and Corporate Finance Report

November 2023 | 20 pages | ID: V201E902E07EN
MarketLine

US$ 175.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Virbac Corporation %li%Strategy, SWOT and Corporate Finance Report

Summary

Virbac Corporation %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Virbac Corporation (Virbac or 'the company'), a subsidiary of Virbac Group, manufactures and markets animal health and pet care products. The company provides pharmaceutical products in the areas of endo%li%and ecto-parasiticides, dermatology, intestinal parasiticides, dental care, antibiotics, behavioral health, endocrinology, euthanasia, hormone, nutrition, and urology. Virbac markets products under Anxitane, C.E.T, Keratolux, Effipro, Epiotic, Ketochlor, Pancrezyme, fleas, Hextra, Knockout, Preventic, Otomite plus, Virbantel, Rilexine, Vetasyl, Spectrum, Suprelorin, Orastrip, Veggiedent, and Allergroom brand names. It also provides healthcare products and services for pets and companion animals. The company is headquartered in Fort Worth, Texas, the US.

Scope
  • Detailed information on Virbac Corporation required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Virbac Corporation in the form of a SWOT analysis
  • An in-depth view of the business model of Virbac Corporation including a breakdown and examination of key business segments
  • Intelligence on Virbac Corporation's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Virbac Corporation, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
  • Gain understanding of Virbac Corporation and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Virbac Corporation as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Virbac Corporation's business structure, strategy and prospects.
Table of Contents
Company Snapshot
Virbac Corporation: Company Overview
Virbac Corporation: Overview and Key Facts
Virbac Corporation: Overview
Virbac Corporation: Key Facts
Virbac Corporation: Key Employees
Virbac Corporation: Key Employee Biographies
Virbac Corporation: Major Products and Services
Virbac Corporation: Locations and Subsidiaries
Virbac Corporation: Key Competitors
Virbac Corporation: Company Analysis
Virbac Corporation: Business Description
Virbac Corporation: SWOT Analysis
Virbac Corporation: SWOT Overview
Virbac Corporation: Strengths
Virbac Corporation: Weaknesses
Virbac Corporation: Opportunities
Virbac Corporation: Threats
Virbac Corporation: Recent Developments
Virbac Corporation: News and Events Summary
Virbac Corporation: Financial Performance
Appendix
Contact Us
Methodology
About MarketLine

LIST OF TABLES

Table 1: Virbac Corporation: Key Facts
Table 2: Virbac Corporation: Key Employees
Table 3: Virbac Corporation: Locations and Subsidiaries
Table 4: Virbac Corporation: Key Competitors
Table 5: Virbac Corporation: News and Events Summary
Table 6: Virbac Corporation: Financial Performance


More Publications